Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myosin-Light-Chain Kinase | 2 | 2018 | 40 | 1.320 |
Why?
|
| Alternative Splicing | 2 | 2018 | 194 | 1.200 |
Why?
|
| Paired Box Transcription Factors | 4 | 2012 | 51 | 0.970 |
Why?
|
| Cortactin | 1 | 2022 | 11 | 0.940 |
Why?
|
| Endothelial Cells | 3 | 2022 | 396 | 0.930 |
Why?
|
| Actins | 1 | 2022 | 438 | 0.740 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 2018 | 2 | 0.710 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2018 | 30 | 0.690 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 111 | 0.670 |
Why?
|
| Stress, Mechanical | 1 | 2017 | 245 | 0.580 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2010 | 1168 | 0.520 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 277 | 0.510 |
Why?
|
| Repressor Proteins | 3 | 2018 | 399 | 0.510 |
Why?
|
| Lung | 2 | 2021 | 1104 | 0.480 |
Why?
|
| Melanoma | 3 | 2013 | 432 | 0.470 |
Why?
|
| Acute Lung Injury | 2 | 2022 | 62 | 0.430 |
Why?
|
| Eye Proteins | 2 | 2009 | 123 | 0.420 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2010 | 200 | 0.420 |
Why?
|
| SOXE Transcription Factors | 1 | 2010 | 5 | 0.400 |
Why?
|
| Capillary Permeability | 2 | 2022 | 129 | 0.390 |
Why?
|
| Receptors, Growth Factor | 1 | 2009 | 52 | 0.380 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 529 | 0.340 |
Why?
|
| Disease Progression | 2 | 2010 | 1436 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2303 | 0.340 |
Why?
|
| Pancreatic Neoplasms | 2 | 2009 | 605 | 0.320 |
Why?
|
| Exons | 2 | 2018 | 444 | 0.290 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 646 | 0.280 |
Why?
|
| HEK293 Cells | 2 | 2018 | 607 | 0.280 |
Why?
|
| Mice | 7 | 2022 | 10885 | 0.250 |
Why?
|
| Reactive Oxygen Species | 2 | 2022 | 449 | 0.230 |
Why?
|
| Focal Adhesions | 1 | 2022 | 69 | 0.220 |
Why?
|
| Paxillin | 1 | 2021 | 60 | 0.210 |
Why?
|
| Mitochondrial Dynamics | 1 | 2021 | 48 | 0.210 |
Why?
|
| Cell Adhesion | 1 | 2022 | 414 | 0.210 |
Why?
|
| Base Sequence | 3 | 2017 | 2332 | 0.200 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 2333 | 0.190 |
Why?
|
| Replication Protein A | 1 | 2018 | 16 | 0.180 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 2018 | 3 | 0.180 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 37 | 0.180 |
Why?
|
| Animals | 7 | 2022 | 25899 | 0.170 |
Why?
|
| Electric Impedance | 1 | 2018 | 103 | 0.170 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 72 | 0.160 |
Why?
|
| Introns | 1 | 2018 | 283 | 0.160 |
Why?
|
| Consensus Sequence | 1 | 2017 | 62 | 0.160 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 51 | 0.160 |
Why?
|
| Binding Sites | 1 | 2018 | 1084 | 0.140 |
Why?
|
| Apoptosis | 3 | 2012 | 1655 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2017 | 465 | 0.130 |
Why?
|
| PAX3 Transcription Factor | 2 | 2012 | 11 | 0.130 |
Why?
|
| Protein Binding | 1 | 2018 | 1451 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1120 | 0.130 |
Why?
|
| Computational Biology | 1 | 2017 | 519 | 0.120 |
Why?
|
| Melanocytes | 1 | 2013 | 55 | 0.120 |
Why?
|
| PAX6 Transcription Factor | 2 | 2009 | 10 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 61 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2017 | 1056 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2009 | 1130 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2188 | 0.110 |
Why?
|
| Lipopolysaccharides | 2 | 2022 | 278 | 0.100 |
Why?
|
| Stem Cells | 1 | 2013 | 343 | 0.100 |
Why?
|
| Humans | 9 | 2021 | 81368 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2595 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2009 | 258 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 513 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 539 | 0.080 |
Why?
|
| RNA | 1 | 2010 | 525 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1428 | 0.070 |
Why?
|
| Cell Line | 2 | 2021 | 2474 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 1038 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3054 | 0.070 |
Why?
|
| NADPH Oxidase 4 | 1 | 2022 | 13 | 0.060 |
Why?
|
| Phenotype | 1 | 2009 | 2292 | 0.060 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2022 | 34 | 0.060 |
Why?
|
| GTP Phosphohydrolases | 1 | 2022 | 68 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2022 | 90 | 0.060 |
Why?
|
| Tyrosine | 1 | 2021 | 138 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 426 | 0.050 |
Why?
|
| Swine | 1 | 2022 | 548 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 289 | 0.050 |
Why?
|
| Rats | 2 | 2022 | 3946 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2022 | 693 | 0.050 |
Why?
|
| A549 Cells | 1 | 2018 | 39 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2021 | 1099 | 0.040 |
Why?
|
| Response Elements | 1 | 2018 | 61 | 0.040 |
Why?
|
| Mutation | 1 | 2009 | 3796 | 0.040 |
Why?
|
| Genome | 1 | 2018 | 347 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 918 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1377 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 3072 | 0.030 |
Why?
|
| Maleimides | 1 | 2012 | 29 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 1189 | 0.030 |
Why?
|
| RNA Interference | 1 | 2012 | 357 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2013 | 178 | 0.030 |
Why?
|
| Indoles | 1 | 2012 | 317 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 960 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2008 | 94 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 542 | 0.020 |
Why?
|
| Cell Division | 1 | 2008 | 705 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1545 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 364 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 1727 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 3168 | 0.010 |
Why?
|